Robotics startup cofounded by Synapse CEO is raising funds with exaggerated promises about GM ties

Essential Points

A humanoid robotics startup cofounded by the CEO of bankrupt fintech organization Synapse has canvassed Silicon Valley investors for cash by boasting shut ties and an imminent expenditure from Typical Motors — statements turned down by the automaker.
The company, termed Foundation Robotics Labs, is seeking the final $1 million in money for an $11 million seed spherical, according to paperwork attained by CNBC. The investor pitch claimed GM experienced currently fully commited to an financial investment, together with the Menlo Park-primarily based VC business Tribe Capital.
But, in accordance to GM and 1 of the startup’s founders, most of Foundation’s claims linked to the automaker are exaggerated or untrue.

Supply

Finance

Jeffrey Gundlach sees one of the ‘least healthy’ stock markets of his career, urges 20% cash

November 17, 2025

Jeffrey Gundlach, CEO of DoubleLine Capital LP, speaks during an interview with CNBC on the floor at the New York Stock Exchange in New York City, U.S., May 7, 2025. Brendan McDermid | Reuters Wall Street veteran Jeffrey Gundlach said many assets are extremely overpriced right now, urging investors to keep about 20% of their […]

Finance

Alphabet rallies after Berkshire reveals stake. Why Buffett’s firm likely bought it

November 17, 2025

Key Points Berkshire Hathaway owned roughly $4.3 billion worth of Alphabet as of Sept. 30, making it the firm’s 10th largest equity holding, a filing showed. The Alphabet investment likely came from one of his two lieutenants, Todd Combs or Ted Weschler. Though its size suggests it likely had the blessing of Buffett, who is […]

Finance

Stocks making the biggest moves premarket: Alphabet, Zymeworks, lithium producers, Quantum Computing, Clearwater Analytics and more

November 17, 2025

Check out the companies making headlines in premarket trading. Alphabet — The YouTube and Google owner rose more than 4% after Warren Buffett’s Berkshire Hathaway revealed it took a more than $4 billion stake in Alphabet in the third quarter. Zymeworks and Jazz Pharmaceuticals — Drugmakers Zymeworks and Jazz Pharmaceuticals reported Phase 3 trial results […]